Insulin secretion from oral glucose intake is greater than insulin secretion from IV glucose, termed the incretin effect [13]
Over 9,000 of the side effects have been linked to abdominal distension, diarrhea, vomiting, abdominal pain and other gastrointestinal issues
Illustrative examples of the resolved principle in both ischemia and reperfusion conditions are the studies of BPC 157 therapys effect on severe multiorgan (brain, heart, lung, liver, kidney, and gastrointestinal tract lesions) and vascular failure and occlusion/occlusion-like syndrome [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168]
[DOI] [PubMed] [Google Scholar] 159.Snchez-Garrido M.A., Brandt S.J., Clemmensen C., Mller T.D., DiMarchi R.D., Tschp M.H
However, while Part B covers the insulin and the pump, it generally does not cover needles or syringes for manual insulin administration